Literature DB >> 2661069

Cardiac manifestations of noncardiac tumors. Part II: Direct effects.

B A Weinberg1, D J Conces, B F Waller.   

Abstract

Cardiac manifestations of secondary tumors of the heart exert their effects directly by endocardial, myocardial, epicardial or cavitary deposits (metastatic lesions); indirectly via tumor products such as carcinoma; or mediated by therapy (chemotherapy, radiation) to treat the primary neoplasm. Part II of this review summarizes certain direct effects of noncardiac tumors on the heart including superior and inferior vena cava syndromes, pulmonary artery and vein obstruction or compression, myocardial implants, and intracavitary metastases. Many of these direct effects may be noninvasively diagnosed by computed tomography, magnetic resonance imaging and/or two-dimensional echocardiography.

Entities:  

Mesh:

Year:  1989        PMID: 2661069     DOI: 10.1002/clc.4960120610

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  4 in total

1.  Massive benign pericardial cyst presenting with simultaneous superior vena cava and middle lobe syndromes.

Authors:  Pankaj Kaul; Kalyana Javangula; Shahme A Farook
Journal:  J Cardiothorac Surg       Date:  2008-05-21       Impact factor: 1.637

2.  Hepatocellular carcinoma with tumor thrombus in the inferior vena cava and right atrium.

Authors:  M Kanematsu; T Imaeda; H Minowa; Y Yamawaki; R Mochizuki; H Goto; M Seki; H Doi; S Okumura
Journal:  Abdom Imaging       Date:  1994 Jul-Aug

3.  Cardio-toxicity among patients with sarcoma: a cardio-oncology registry.

Authors:  Sivan Shamai; Zach Rozenbaum; Ofer Merimsky; Matthew Derakhshesh; Yonatan Moshkovits; Joshua Arnold; Yan Topilsky; Yaron Arbel; Michal Laufer-Perl
Journal:  BMC Cancer       Date:  2020-06-30       Impact factor: 4.430

4.  Identification of Subclinical Myocardial Dysfunction in Breast Cancer Patients with Metabolic Syndrome after Cancer-Related Comprehensive Therapy.

Authors:  Feng Zhang; Siyuan Wang; Siying Liang; Chao Yu; Sufang Li; Hong Chen; Shu Wang; Tiangang Zhu
Journal:  Cardiol Res Pract       Date:  2021-03-02       Impact factor: 1.866

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.